Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers
Clinical trial NCT03146416 · COMPLETED
Trial details
- NCT number
- NCT03146416
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2018-06-14
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.